Certified by Founder Lodge
Cognito Therapeutics, Inc.
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $73,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical stud
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 23 ,2023 | Series B | $73,000,000 |
FoundersX Ventures
IAG Capital Partners
Alzheimer's Drug Discovery Foundation
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
